Lung Spheroid Stem Cells 100 million
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
University of North Carolina, Chapel Hill
Overview
Lung Spheroid Stem Cells 100 million is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Lung Spheroid Stem Cells 100 million clinical trials
Explore related
Medical disclaimer. This page summarizes research about Lung Spheroid Stem Cells 100 million for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.